Literature DB >> 29268182

Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.

Sabra S Inslicht1, Madhu N Rao2, Anne Richards3, Aoife O'Donovan3, Carolyn J Gibson4, Tierney Baum5, Thomas J Metzler3, Thomas C Neylan3.   

Abstract

Disturbed sleep is a core feature of posttraumatic stress disorder (PTSD), characterized in part by decreased delta power sleep that may result from stress-related alterations in corticotropin releasing factor (CRF), hypothalamic pituitary adrenal axis (HPA) regulation and glucocorticoid signaling. Overnight HPA axis response mediating sleep disturbances in men and women with PTSD was examined using a metyrapone challenge. Metyrapone blocks cortisol synthesis, removing negative feedback, and increases the release of hypothalamic CRF and pituitary adrenocorticotropic hormone (ACTH). Laboratory-based polysomnography was used to monitor the sleep of 66 medically healthy, medication-free men and pre-menopausal follicular phase women including 33 with chronic PTSD (16 women and 17 men) and 33 age- and sex-matched controls (14 women and 19 men) over 3 consecutive nights. Participants completed an overnight metyrapone challenge after an adaptation and baseline night of sleep and ACTH was obtained by repeated blood sampling. Metyrapone resulted in a greater increase in ACTH and greater decreases in cortisol and delta spectral power sleep in PTSD subjects compared to controls, and a greater increase in ACTH in women compared to men. There was no sex difference in metyrapone effects on delta power sleep, and no significant metyrapone by PTSD by sex interactions with either ACTH or delta power sleep. Regression analyses indicated that a greater increase in ACTH response was associated with a greater decrease in delta power sleep response in PTSD subjects, but no such relationship was found in controls. The PTSD group difference was similar in men and women. These results suggest that stress-related alterations of the HPA axis in PTSD may contribute to sleep difficulties. Therapeutics that target the HPA axis may offer promise as a potential future treatment for PTSD and related sleep difficulties. Published by Elsevier Ltd.

Entities:  

Keywords:  ACTH; Metyrapone; Posttraumatic stress disorder; Sex differences; Sleep

Mesh:

Substances:

Year:  2017        PMID: 29268182      PMCID: PMC6170159          DOI: 10.1016/j.psyneuen.2017.12.002

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  35 in total

1.  A diurnal rhythm in cerebrospinal fluid corticotrophin-releasing hormone different from the rhythm of pituitary-adrenal activity.

Authors:  N H Kalin; S E Shelton; C M Barksdale; M S Brownfield
Journal:  Brain Res       Date:  1987-11-24       Impact factor: 3.252

2.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Authors:  R L Spitzer; J B Williams; M Gibbon; M B First
Journal:  Arch Gen Psychiatry       Date:  1992-08

Review 3.  Light sleep versus slow wave sleep in memory consolidation: a question of global versus local processes?

Authors:  Lisa Genzel; Marijn C W Kroes; Martin Dresler; Francesco P Battaglia
Journal:  Trends Neurosci       Date:  2013-11-07       Impact factor: 13.837

4.  Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder.

Authors:  Sabra S Inslicht; Anne Richards; Erin Madden; Madhu N Rao; Aoife O'Donovan; Lisa S Talbot; Evelyn Rucker; Thomas J Metzler; Richard L Hauger; Thomas C Neylan
Journal:  Psychopharmacology (Berl)       Date:  2014-06-21       Impact factor: 4.530

5.  Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder.

Authors:  Andreas Ströhle; Michael Scheel; Sieglinde Modell; Florian Holsboer
Journal:  J Psychiatr Res       Date:  2008-03-14       Impact factor: 4.791

6.  Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects.

Authors:  Frederic J Sautter; Garth Bissette; Justin Wiley; Gina Manguno-Mire; Benjamin Schoenbachler; Leann Myers; Janet E Johnson; Arleen Cerbone; Dolores Malaspina
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

7.  Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input.

Authors:  R J Valentino; M Page; E Van Bockstaele; G Aston-Jones
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

8.  Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder.

Authors:  C S de Kloet; E Vermetten; E Geuze; E G W M Lentjes; C J Heijnen; G K Stalla; H G M Westenberg
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

9.  Slow-wave sleep and the risk of type 2 diabetes in humans.

Authors:  Esra Tasali; Rachel Leproult; David A Ehrmann; Eve Van Cauter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-02       Impact factor: 11.205

Review 10.  The hypothalamic-pituitary-adrenocortical system and sleep in man.

Authors:  E Friess; K Wiedemann; A Steiger; F Holsboer
Journal:  Adv Neuroimmunol       Date:  1995
View more
  3 in total

Review 1.  Sleep, a Governor of Morbidity in PTSD: A Systematic Review of Biological Markers in PTSD-Related Sleep Disturbances.

Authors:  Daniel G Maguire; Mark W Ruddock; Melissa E Milanak; Tara Moore; Diego Cobice; Cherie Armour
Journal:  Nat Sci Sleep       Date:  2020-07-31

Review 2.  Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms.

Authors:  Anne Richards; Jennifer C Kanady; Thomas C Neylan
Journal:  Neuropsychopharmacology       Date:  2019-08-23       Impact factor: 7.853

3.  Sleep spindle dynamics suggest over-consolidation in post-traumatic stress disorder.

Authors:  Anna C van der Heijden; Winni F Hofman; Marieke de Boer; Mirjam J Nijdam; Hein J F van Marle; Ruud A Jongedijk; Miranda Olff; Lucia M Talamini
Journal:  Sleep       Date:  2022-09-08       Impact factor: 6.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.